沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

已收盘 12-05 16:09:08

5.540

+0.040

+0.73%

最高5.620	最低5.360	成交量101.37万
今开5.510	昨收5.500	日振幅4.73%
总市值37.17亿	流通市值37.17亿	总股本6.71亿
成交额561.87万	换手率0.15%	流通股本6.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":5.54,"timestamp":1764922148009,"preClose":5.5,"halted":0,"volume":1013696,"delay":0,"floatShares":671000000,"shares":671000000,"eps":-0.3727877922627851,"marketStatus":"已收盘","change":0.04,"latestTime":"12-05 16:09:08","open":5.51,"high":5.62,"low":5.36,"amount":5618716,"amplitude":0.047273,"askPrice":5.57,"askSize":7000,"bidPrice":5.53,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.3742373897719312,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":5.5,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.63379,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2588235880","title":"新华医疗（600587）披露公司产品获得二类医疗器械注册证，12月04日股价上涨0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588235880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588235880?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:23","pubTimestamp":1764858198,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，新华医疗报收于15.04元，较前一交易日上涨0.33%，最新总市值为91.24亿元。该股当日开盘14.99元，最高15.09元，最低14.92元，成交额达5260.55万元，换手率为0.58%。近日，新华医疗发布公告称，山东新华医疗器械股份有限公司及控股子公司新华手术器械有限公司近日获得山东省药品监督管理局颁发的两项二类医疗器械注册证。产品分别为手术无影灯和胸腹腔内窥镜，批准日期分别为2025年11月27日和2025年11月19日，有效期均至2030年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","600587","BK1583","BK1222","BK0188","BK1100","159883","09997","09996","BK0251","BK0028"],"gpt_icon":0},{"id":"2588009650","title":"新华医疗(600587.SH)产品获得二类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2588009650","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588009650?lang=zh_cn&edition=full","pubTime":"2025-12-04 15:42","pubTimestamp":1764834124,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华医疗(600587.SH)发布公告，公司和控股子公司新华手术器械有限公司于近日收到山东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》。手术无影灯满足了临床不同手术照明的需求，进一步丰富了公司手术室产品线，胸腹腔内窥镜可适配公司医用荧光内窥镜摄像系统和微创腔镜手术器械，丰富公司微创腔镜手术产品种类，有利于提升公司的核心竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK1222","BK0028","09997","159883","BK0188","BK1574","600587","BK1583","BK1100","09996"],"gpt_icon":0},{"id":"2588076380","title":"【券商聚焦】中泰国际：北京与上海相继出台政策支持创新医疗器械的开发 料有利于创新医疗器械板块发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2588076380","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588076380?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:04","pubTimestamp":1764810245,"startTime":"0","endTime":"0","summary":"医疗器械板块上涨，该机构估计是由于北京与上海相继出台政策支持创新医疗器械开发。北京出台《北京市促进医疗器械产业高质量发展若干措施》，提出多条举措支持创新器械的临床研发、注册上市、销售推广、产业链发展和出海。该机构认为以上政策有利于创新医疗器械板块的发展，但港股大型创新医疗器械生产商不多，该机构对传统医疗器械生产商的2025年业绩偏谨慎。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970861","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066","LU0140636845.USD","159883","LU0819121731.USD","BK1191","LU2097828714.EUR","LU1969619763.USD","LU2242644610.SGD","LU0456827905.SGD","09997","01801","LU0051755006.USD","LU0359201612.USD","LU0456846285.SGD","LU0516423091.SGD","IE00BZ08YT58.USD","LU2097828631.EUR","LU2097828474.EUR","BK1574","BK1583","01177","LU0823426308.USD","LU0173614495.USD","LU2097828805.USD","LU3063872942.SGD","LU0856984785.SGD","LU2039709279.SGD","09996","LU0348825331.USD","LU0348735423.USD","HK0000165453.HKD","LU2488822045.USD","BK1100","02269","LU0516423174.USD","BK1141","LU2045819591.USD","LU0359202008.SGD","LU0708995583.HKD","LU1880383366.USD","LU0455707207.USD","02359","LU2125910500.SGD","BK1161","LU0823426480.USD","LU0307460666.USD","SG9999002463.SGD","03692","IE00B0JY6N72.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2588022699","title":"每日卖空追踪 | 沛嘉医疗-B 12月03日卖空量成交7.1万股，卖空比例为7.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588022699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588022699?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750637,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间12月03日，涨1.12%，卖空量成交7.1万股，较上一交易日减少62.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163654a4c9f166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163654a4c9f166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","09996","BK1583","BK1574"],"gpt_icon":0},{"id":"2588501059","title":"安图生物（603658）披露公司及子公司获得医疗器械注册证，12月2日股价下跌1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588501059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588501059?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:12","pubTimestamp":1764684773,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，安图生物报收于36.07元，较前一交易日下跌1.23%，最新总市值为206.11亿元。近日，安图生物发布公告称，郑州安图生物工程股份有限公司及子公司思昆生物、郑州标源近日获得多项医疗器械注册证，涉及基因测序仪、中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒、壳多糖酶3样蛋白1检测试剂盒、抗U1核糖核蛋白抗体IgG检测试剂盒、高血压标志物质控品及骨代谢标志物质控品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK1583","159883","BK1574","BK1100","BK1222","09997","BK0046","09996"],"gpt_icon":0},{"id":"2588793037","title":"集采压力与研发加速背景下，医疗器械经理人的“第二曲线”是...","url":"https://stock-news.laohu8.com/highlight/detail?id=2588793037","media":"赛柏蓝器械","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588793037?lang=zh_cn&edition=full","pubTime":"2025-12-02 19:18","pubTimestamp":1764674280,"startTime":"0","endTime":"0","summary":"值得注意的是，尽管AIGC工具为医疗器械行业带来了诸多便利，但其核心价值在于如何更好地服务于人类决策者，而非取代他们。这一培训项目提供了一个系统学习的机会，对于医疗器械经理人来说，更重要的是理解AI作为工具如何融入日常工作流程，以增强个人及团队的核心竞争力，并适应行业的数字化转型趋势。让我们共同探索AI如何成为医疗器械经理人的得力助手，推动整个行业向着更加智能化的方向发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-02/doc-infzmiff0292634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09996","09997","159883","BK1222","BK1583","BK1100"],"gpt_icon":0},{"id":"2588394039","title":"安图生物(603658.SH)及子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2588394039","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588394039?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:43","pubTimestamp":1764668613,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安图生物(603658.SH)发布公告，公司及全资子公司郑州思昆生物工程有限公司(简称“思昆生物”)、二级子公司郑州标源生物科技有限公司(简称“郑州标源”)分别于近日收到国家药品监督管理局、河南省药品监督管理局颁发的医疗器械注册证。上述医疗器械注册证的取得进一步丰富了公司产品菜单，不断满足市场需求，是对公司现有检测产品的有效补充，可以逐步提高公司产品的整体竞争力，短期内对公司的经营业绩影响较小。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","BK0046","603658","BK1222","BK0239","159883","09997","09996","BK1100"],"gpt_icon":0},{"id":"1154273777","title":"沛嘉医疗（09996）更新2025年11月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1154273777","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154273777?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:40","pubTimestamp":1764661249,"startTime":"0","endTime":"0","summary":"沛嘉医疗有限公司（09996）于2025年12月2日发布2025年11月股份变动月报表。公告显示，截至2025年11月30日，公司注册股本总额维持在1,000,000,000股，面值为每股USD 0.0001，总注册资金约USD 100,000。该数值与上月底相比无增减。\n报告期内，公司已发行普通股数量保持在671,438,159股，未见新增发行、购回或注销活动，亦无库存股份变动。公司所设购股权计划方面，期末结存数量总体维持不变，未有新增授出或行使。\n公司表示，已遵守香港联交所上市规则及相关法律法规规定。本次月报表经董事会正式授权批准，并由公司董事张一签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996"],"gpt_icon":0},{"id":"2588773211","title":"高视医疗(02407)附属获得医疗器械质量管理体系国际认证证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2588773211","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588773211?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:11","pubTimestamp":1764598265,"startTime":"0","endTime":"0","summary":"智通财经APP讯，高视医疗 发布公告，公司附属公司深圳高视科技有限公司于近日正式获得由DEKRA签发的符合ISO 13485：2016/EN ISO 13485：2016医疗器械质量管理体系认证证书。ISO 13485是国际标准化组织发布的医疗器械行业专用质量管理体系标准，聚焦“以患者为中心”的风险管理与全流程质量控制，是全球医疗器械监管机构认可的核心合规性依据。本次重要资质的获得，是公司在质量管理体系建设上的又一重要成果，为公司持续开拓国际市场奠定了坚实基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1222","BK1574","09996","BK1100","159883","BK1583","02407"],"gpt_icon":0},{"id":"2588472610","title":"透景生命最新公告：全资子公司江西透景申报的医疗器械注册申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2588472610","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588472610?lang=zh_cn&edition=full","pubTime":"2025-12-01 18:20","pubTimestamp":1764584401,"startTime":"0","endTime":"0","summary":"透景生命(300642.SZ)公告称，全资子公司江西透景申报的4项医疗器械注册申请近日获得江西省药品监督管理局受理，包括2项全自动流式荧光发光免疫分析仪和2项全自动化学发光免疫分析仪。这些产品均为第二类体外诊断仪器，不同型号的受理有利于丰富公司及全资子公司在流式荧光及化学发光产品线的仪器配套，提高市场竞争力。但注册申请受理对公司及江西透景近期业绩不会产生影响，能否顺利取得医疗器械注册证书有待于江西省药品监督管理局的最终审评结论。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100025044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","09996","BK1100","159883","09997","BK0046","300642","BK1222","BK1583","BK0042","BK1574"],"gpt_icon":0},{"id":"2588706935","title":"每日卖空追踪 | 沛嘉医疗-B 12月01日卖空量成交5.2万股，卖空比例为4.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588706935?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577840,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间12月01日，跌2.43%，卖空量成交5.2万股，较上一交易日增加73.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116363097895721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116363097895721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1100","BK1583","BK1574"],"gpt_icon":0},{"id":"2588270693","title":"沛嘉医疗-B12月01日遭主力抛售161.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588270693","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588270693?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576934,"startTime":"0","endTime":"0","summary":"12月01日, 沛嘉医疗-B股价跌2.43%，报收5.21元，成交金额615.4万元，换手率0.18%，振幅5.24%，量比1.99。沛嘉医疗-B今日主力资金净流出161.2万元，连续3日净流出，上一交易日主力净流出73.6万元。该股近5个交易日下跌2.07%，主力资金累计净流出308.5万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出174.1万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173597894b7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173597894b7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1100","09996"],"gpt_icon":0},{"id":"2587795894","title":"医疗器械行业：关注25Q4消费及下游端需求回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2587795894","media":"广发证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587795894?lang=zh_cn&edition=full","pubTime":"2025-11-29 17:33","pubTimestamp":1764408803,"startTime":"0","endTime":"0","summary":"根据wind，25Q3，A 股医疗器械板块整体收入同比提升4.4%，环比25Q2 下滑2.2%；整体归母净利润同比下滑6.3%，环比25Q2 下滑16.3%。25Q3 整体行业业绩预计受行业周期影响下滑，预计25Q4 行业业绩将有所恢复。利润方面，25Q3设备行业归母净利润同比下滑3.0%，环比25Q2 下滑21.60%，预计主要系多数设备企业持续加大费用投入，以保持市场竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251129173326a71927b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251129173326a71927b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02190","BK1583","BK1574","01789","BK1100","09997","BK1222","09996"],"gpt_icon":0},{"id":"2586010762","title":"陇神戎发(300534.SZ)获得血液透析浓缩液医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586010762","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586010762?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:56","pubTimestamp":1764316572,"startTime":"0","endTime":"0","summary":"智通财经APP讯，陇神戎发(300534.SZ)发布公告，公司于2025年11月28日获得由国家药品监督管理局颁发的血液透析浓缩液《中华人民共和国医疗器械注册证》。血液透析浓缩液由A浓缩液和B浓缩液两部分组成。A浓缩液由氯化钠(NaCl)、氯化钾(KCl)、氯化钙(CaCl2·2H2O)、氯化镁(MgCl2·6H2O)、冰醋酸(CH3COOH)及透析用水组成，B浓缩液由碳酸氢钠(NaHCO3)和透析用水组成。适用范围：用于急性肾衰竭、慢性肾衰竭的血液透析治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","09996","09997","BK0056","BK1100","300534","BK0132","BK1583","BK1574","BK1222","BK0239"],"gpt_icon":0},{"id":"2586722510","title":"凯普生物（300639）披露全资子公司变更医疗器械生产许可证，11月27日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586722510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586722510?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:25","pubTimestamp":1764253523,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，凯普生物报收于5.93元，较前一交易日上涨0.34%，最新总市值为38.34亿元。该股当日开盘5.9元，最高5.95元，最低5.85元，成交额达3111.22万元，换手率为0.83%。公司近日发布公告称，其全资子公司潮州凯普生物化学有限公司收到广东省药品监督管理局颁发的《医疗器械生产许可证》，主要涉及生产范围的变更。许可证有效期至2029年1月8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1222","BK1583","BK0046","09996","BK0042","BK1100","159883","300639","BK0132","BK1574","BK0239"],"gpt_icon":0},{"id":"2586722558","title":"安图生物（603658）披露公司及全资子公司获得医疗器械注册证，11月27日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586722558","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586722558?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:12","pubTimestamp":1764252739,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，安图生物报收于36.75元，较前一交易日下跌0.35%，最新总市值为210亿元。该股当日开盘36.88元，最高37.0元，最低36.61元，成交额达6717.37万元，换手率为0.32%。注册证有效期均为5年。上述产品注册证的取得将丰富公司产品线，短期内对公司经营业绩影响较小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","09996","BK1583","BK1100","09997","BK1222","BK0046","603658","BK0239","BK1574"],"gpt_icon":0},{"id":"2586228968","title":"合规“通行证”到手：凯普生物（300639）子公司新增多类医疗器械生产资质，有效期至2029年","url":"https://stock-news.laohu8.com/highlight/detail?id=2586228968","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586228968?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:14","pubTimestamp":1764245640,"startTime":"0","endTime":"0","summary":"11月27日，凯普生物（300639）发布公告，近日公司全资子公司潮州凯普生物化学有限公司收到了广东省药品监督管理局颁发的《医疗器械生产许可证》。　　此次许可证的变更主要涉及生产范围，新的生产范围包括Ⅲ类6840体外诊断试剂、Ⅱ类18妇产科、辅助生殖和避孕器械，以及Ⅱ类22临床检验器械。许可证的有效期至2029年1月8日，许可证编号为粤食药监械生产许20041040号。　　2025年前三季度，凯普生物实现收入4.86亿元，归母净利润-1.28亿元。（文章来源：财中社）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-27/doc-infywcvy9114614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","BK0239","300639","BK1583","BK1222","BK0132","09996","BK1100","BK1574","09997","BK0046","BK0042"],"gpt_icon":0},{"id":"2586243595","title":"安图生物(603658.SH)及子公司取得多项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586243595","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586243595?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:57","pubTimestamp":1764233868,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安图生物(603658.SH)发布公告，公司及全资子公司安图实验仪器(郑州)有限公司(简称“安图仪器”)于近日收到河南省药品监督管理局颁发的多项医疗器械注册证。上述医疗器械注册证的取得进一步丰富了公司产品菜单，不断满足市场需求，是对公司现有检测产品的有效补充，可以逐步提高公司产品的整体竞争力，短期内对公司的经营业绩影响较小。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603658","09996","BK1583","159883","BK1574","09997","BK1222","BK0046","BK0239","BK1100"],"gpt_icon":0},{"id":"2586439142","title":"戴维医疗最新公告：婴儿辐射保暖台医疗器械产品注册证完成变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2586439142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586439142?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:56","pubTimestamp":1764233799,"startTime":"0","endTime":"0","summary":"戴维医疗(300314.SZ)公告称，公司近日取得国家药品监督管理局颁发的《医疗器械变更注册（备案）文件》，产品婴儿辐射保暖台完成了医疗器械产品注册变更，主要变更内容为因产品适用的强制性标准更新，变更产品技术要求。此次变更符合公司生产经营实际，对公司发展具有积极影响，但尚无法预测对未来营业收入的影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700024206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300314","09996","BK0251","BK0042","159883","BK0048","BK1100","BK1222","BK1574","BK1583","09997"],"gpt_icon":0},{"id":"2586210666","title":"万东医疗(600055.SH)收到一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586210666","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586210666?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:04","pubTimestamp":1764230665,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万东医疗(600055.SH)公告，公司近日收到国家药品监督管理局颁发的《医疗器械注册证》，相关产品名称为：X射线计算机体层摄影设备。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0146","BK1574","BK1222","BK1100","BK0251","BK0070","09996","600055","09997","BK0114","159883","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0.0223},{"period":"1month","weight":-0.0468},{"period":"3month","weight":-0.2792},{"period":"6month","weight":0.0055},{"period":"1year","weight":0.4706},{"period":"ytd","weight":0.3819}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.088172},{"month":2,"riseRate":0.6,"avgChangeRate":0.039503},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.067758}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}